Correlates of excessive daytime sleepiness in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 11, Issue 7, 2005, Pages 441-448

  Wegelin, Jacob ^a   McNamara, Patrick ^b,c   Durso, Raymon ^b,c   Brown, Ariel ^b,c   McLaren, Deirdre ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Dopamine agonists; Excessive daytime sleepiness; Executive functions; Mood; Neuropsychology; Parkinson's disease

Indexed keywords

CARBIDOPA PLUS LEVODOPA; PRAMIPEXOLE;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; MOOD; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; RELIABILITY; SLEEP TIME; SOMNOLENCE;

AFFECT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; ANXIETY; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SLEEP STAGES;

EID: 27344437981     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2005.05.007     Document Type: Article

References (54)

1. S. Kumar, M. Bhatia, and M. Behari Sleep disorders in Parkinson's disease Mov Disord 17 4 2002 775 781
2. A.J. Lees, N.A. Blackburn, and V.L. Campbell The nighttime problems of Parkinson's disease Clin Neuropharmacol 11 6 1988 512 519
3. M. Partinen Sleep disorder related to Parkinson's disease J Neurol 244 4 Suppl. 1 1997 S3 S6
4. S. Happe, and K. Berger The association between caregiver burden and sleep disturbances in partners of patients with Parkinson's disease Age Ageing 31 2002 349 354
5. S. Happe, P. Ludemann, and K. Berger The association between disease severity and sleep-related problems in patients with Parkinson's disease Neuropsychobiology 46 2 2002 90 96
6. K. Karlsen, J.P. Larsen, E. Tandberg, and K. Jorgensen Fatigue in patients with Parkinson's disease Mov Disord 14 2 1999 237 241
7. J.P. Larsen, and E. Tandberg Sleep disorders in patients with Parkinson's disease: epidemiology and management CNS Drugs 15 4 2001 267 275
8. M. Stacy Sleep disorders in Parkinson's disease: epidemiology and management Drugs Aging 19 10 2002 733 739
9. F. Stocchi, L. Vacca, M. Valente, and S. Ruggieri Sleep disorders in Parkinson's disease Adv Neurol 86 2001 289 293
10. S. Kumar, M. Bhatia, and M. Behari Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS) Sleep Med 4 4 2003 339 342
11. E. Tandberg, J.P. Larsen, and K. Karlsen Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study Mov Disord 14 6 1999 922 927
12. B. Hogl, K. Seppi, E. Brandauer, S. Glatzl, B. Frauscher, U. Niedermuller, G. Wenning, and W. Poewe Increased daytime sleepiness in Parkinson's disease: a questionnaire survey Mov Disord 18 3 2003 319 323
13. M.D. Gjerstad, D. Aarsland, and J.P. Larsen Development of daytime somnolence over time in Parkinson's disease Neurology 58 10 2002 1544 1546
14. M.A. Brodsky, J. Godbold, T. Roth, and C.W. Olanow Sleepiness in Parkinson's disease: a controlled study Mov Disord 18 6 2003 668 672
15. I. Arnulf, E. Konofal, M. Merino-Andreu, J.L. Houeto, V. Mesnage, M.L. Welter, L. Lacomblez, J.L. Golmard, J.P. Derenne, and Y. Agid Parkinson's disease and sleepiness: an integral part of PD Neurology 58 7 2002 1019 1024
16. P.K. Pal, K. Thennarasu, J. Fleming, M. Schulzer, T. Brown, and S.M. Calne Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson's disease and in their caregivers Parkinsonism Relat Disord 10 3 2004 157 168
17. B. van Hilten, J.I. Hoff, H.A. Middelkoop, E.A. van der Velde, G.A. Kerkhof, A. Wauquier, H.A. Kamphuisen, and R.A. Roos Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring Arch Neurol 51 9 1994 922 928
18. S. Frucht, J.D. Rogers, P.E. Greene, M.F. Gordon, and S. Fahn Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole Neurology 52 9 1999 1908 1910
19. A. Razmy, A.E. Lang, and C.M. Shapiro Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs. newer (non-ergot) dopamine agonists Arch Neurol 61 1 2004 97 102
20. H. Furumoto Excessive daytime somnolence in Japanese patients with Parkinson's disease Eur J Neurol 11 8 2004 535 540
21. C.G. Goetz, S. Leurgans, E.J. Pappert, R. Raman, and A.B. Stemer Prospective longitudinal assessment of hallucinations in Parkinson's disease Neurology 57 11 2001 2078 2082
22. I. Arnulf, A.M. Bonnet, P. Damier, B.P. Bejjani, D. Seilhean, J.P. Derenne, and Y. Agid Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis Neurology 55 2 2000 281 288
23. A.J. Hughes, S.E. Daniel, L. Kilford, and A.J. Lees Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 3 1992 181 184
24. M.M. Hoehn, and M.D. Yahr Parkinsonism: onset, progression, and mortality. 1967 Neurology 57 10 Suppl. 3 2001 S11 S26
25. M.W. Johns A new method for measuring daytime sleepiness: the Epworth sleepiness scale Sleep 14 6 1991 540 545
26. T. Shallice Specific impairments of planning Philos Trans R Soc Lond B Biol Sci 298 1089 1982 199 209
27. M.D. Lezak Neuropsychological assessment 3rd ed 1995 Oxford University Press New York
28. S.H. Lovibond, and P.F. Lovibond Manual for the depression anxiety stress scales 1995 The Psychology Foundation of Australia Sydney
29. J.R. Crawford, and J.D. Henry The Depression anxiety stress scales (DASS): normative data and latent structure in a large non-clinical sample Br J Clin Psychol 42 Pt 2 2003 111 131
30. M.M. Antony, P.J. Bieling, B.J. Cox, M.W. Enns, and R.P. Swinson Psychometric properties of the 42-item and 21-item versions of the Depression anxiety stress scales (DASS) in clinical groups and a community sample Psychol Assess 10 1998 176 181
31. Y. Benjamini, D. Drai, G. Elmer, N. Kafkafi, and I. Golani Controlling the false discovery rate in behavior genetics research Behav Brain Res 125 1-2 2001 279 284
32. T.S. Lee, T. Eid, S. Mane, J.H. Kim, D.D. Spencer, O.P. Ottersen, and N.C. de Lanerolle Aquaporin-4 is increased in the sclerotic hippocampus in human temporal lobe epilepsy Acta Neuropathol (Berl) 108 6 2004 493 502
33. P. McNamara, R. Durso, and S. Auerbach Dopaminergic syndromes of sleep, mood and mentation: evidence form Parkinson's disease and related disoerders Sleep Hypnosis 4 4 2002 119 131
34. J.P. Wisor, S. Nishino, I. Sora, G.H. Uhl, E. Mignot, and D.M. Edgar Dopaminergic role in stimulant-induced wakefulness J Neurosci 21 5 2001 1787 1794
35. S. Nishino, J. Mao, R. Sampathkumaran, and J. Shelton Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants Sleep Res Online 1 1 1998 49 61
36. J.P. Aggleton The amygdala: a functional analysis 2000 Oxford University Press Oxford
37. A.F. Sadikot, and A. Parent The monoaminergic innervation of the amygdala in the squirrel monkey: an immunohistochemical study Neuroscience 36 2 1990 431 447
38. S.N. Haber, and J.L. Fudge The interface between dopamine neurons and the amygdala: implications for schizophrenia Schizophr Bull 23 3 1997 471 482
39. M. Davis The role of the amygdala in conditions and unconditioned fear and anxiety J.P. Aggleton The amygdala. A functional analysis 2nd ed 2000 Oxford University Press Oxford 231 288
40. P. Maquet, and G. Franck REM sleep and amygdala Mol Psychiatry 2 3 1997 195 196
41. P. Maquet, and C. Phillips Rapid eye movement sleep: from cerebral metabolism to functional brain mapping S. Inoue Rapid eye movement sleep 1999 Marcel Dekker New York 276 285
42. Y. Agid, M. Javoy-Agid, and M. Ruberg Biochemistry of neurotransmitters in Parkinson's disease CD Marsden S Fahn Movement Disorders 2 1987 Butterworth's and Co. London 166 230
43. E.J. Olson, B.F. Boeve, and M.H. Silber Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases Brain 123 Pt 2 2000 331 339
44. R.L. Albin, R.A. Koeppe, R.D. Chervin, F.B. Consens, K. Wernette, K.A. Frey, and M.S. Aldrich Decreased striatal dopaminergic innervation in REM sleep behavior disorder Neurology 55 9 2000 1410 1412
45. D. Weintraub, A.B. Newberg, M.S. Cary, A.D. Siderowf, P.J. Moberg, G. Kleiner-Fisman, J.E. Duda, M.B. Stern, D. Mozley, and I.R. Katz Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease J Nucl Med 46 2 2005 227 232
46. F. Javoy-Agid, and Y. Agid Is the mesocortical dopaminergic system involved in Parkinson's disease? Neurology 30 1980 1326 1330
47. B. Scatton, F. Javoy-Agid, L. Rouquier, B. Dubois, and Y. Agid Reduction of cortical dopamine, neuroadrenaline, seratonin, and their metabolites in Parkinson's disease Brain Res 275 1983 321 328
48. H. Shinotoh, and D. Calne The use of PET in Parkinson's disease Brain Cog 28 1995 297 310
49. R.M. Torack, and J.C. Morris The association of ventral tegmental area histopathology with adult dementia Arch Neurol 45 5 1988 497 501
50. D. German, K. Manaye, W. Smith, D. Woodward, and C. Saper Mid-brain dopaminergic cell loss in Parkinson's disease: Computer visualization Annals Neurol 26 1989 507 514
51. J.O. Rinne, J. Rummukainen, L. Paljarvi, and U.K. Rinne Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra Annals Neurol 26 1989 47 50
52. K.A. Jellinger, K. Seppi, G.K. Wenning, and W. Poewe Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease J Neural Transm 109 3 2002 329 339
53. M. Emre What causes mental dysfunction in Parkinson's disease? Movement Disorders 18 Suppl. 6 2003 563 571
54. H. Buschke Selective reminding for analysis of memory and learning J Verbal Learning Verbal Behavior 12 1973 543 550